Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Science Translational Medicine
|
September 27, 2023
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V Tse, Yixuan J Hou, Elizabeth McFadden, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2020
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication <i>ex vivo</i> and Earlier Transmission <i>in vivo</i>
Yixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Cell
|
October 8, 2020
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Sarah R Leist, Kenneth H Dinnon, Alexandra Schäfer, et al.
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Mbio
|
May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2
Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Nature Communications
|
October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Matthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Science (New York, N.Y.)
|
November 13, 2020
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Biorxiv : the Preprint Server for Biology
|
December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Science Translational Medicine
|
September 27, 2023
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V Tse, Yixuan J Hou, Elizabeth McFadden, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2020
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication <i>ex vivo</i> and Earlier Transmission <i>in vivo</i>
Yixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Cell
|
October 8, 2020
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Sarah R Leist, Kenneth H Dinnon, Alexandra Schäfer, et al.
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Mbio
|
May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2
Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Nature Communications
|
October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Matthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Science (New York, N.Y.)
|
November 13, 2020
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Biorxiv : the Preprint Server for Biology
|
December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Page
of 5